Skip to main content

ABI Reports Increased Revenues for 4th Quarter

Click herefor an updated version of this story.

 

NEW YORK, July 23 - Applied Biosystems of Applera this morning reported net revenues of $432.9 million for the fourth quarter ending June 30, up over $417 million for the same quarter of 2002, the Foster City, Calif.-based company said in a statement.

 

The company reported net income of $96.1 million for the quarter, compared to $38.2 million for the year-ago period.

 

The company recorded research and development charges of $58.2 million, compared to $58.0 million for the same quarter in 2002.

 

"In light of the challenging business environment, I am pleased that Applied Biosystems achieved solid earnings growth and strong cash flow from operations during the fourth quarter," said Michael Hunkapiller, president, ABI, said in a statement.

 

The company on Tuesday said that it plans to launch a whole-genome microarray product.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.